MedPath

ENZYME TABLETS

ENZYME TABLETS

Discontinued
DIN Number

02181312

Drug Class

Human

Market Date

Oct 20, 2001

Company
HC

general nutrition canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02181312
AIG Number0627946001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AC02 MULTIENZYMES AND ACID PREPARATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

AMYLASEActive
Strength: 130 MG
Monograph: AMYLASE
BETAINE HYDROCHLORIDEActive
Strength: 65 MG
Monograph: BETAINE HYDROCHLORIDE
OX BILE EXTRACTActive
Strength: 8.125 MG
Monograph: OX BILE EXTRACT
PANCREATINActive
Strength: 100 MG
Monograph: PANCREATIN
PAPAINActive
Strength: 65 MG
Monograph: PAPAIN
PEPSINActive
Strength: 65 MG
Monograph: PEPSIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.